SCHEMBL21615871

SCHEMBL21615871

CCCCCCC(=O)NC(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.61
POLB P06746 1/20 0.60
CES2 O00748 2/20 0.58
CES1 P23141 2/20 0.58
EPHX2 P34913 1/20 0.58
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
ALDH1A1 P00352 1/20 0.56
PKM P14618 1/20 0.56
HDAC1 Q13547 5/20 0.55
HDAC8 Q9BY41 5/20 0.55
HDAC3 O15379 3/20 0.55
HDAC4 P56524 3/20 0.55
HDAC2 Q92769 3/20 0.55
HDAC10 Q969S8 3/20 0.55
HDAC11 Q96DB2 3/20 0.55
HDAC6 Q9UBN7 3/20 0.55
HDAC9 Q9UKV0 3/20 0.55
HDAC5 Q9UQL6 3/20 0.55
GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1343140 1.00 NAAA (0.61) NAAAPOLBCES2CES1EPHX2
SCHEMBL3947433 1.00 NAAA (0.61) NAAAPOLBCES2CES1EPHX2
SCHEMBL5696563 0.98 POLB (0.61) NAAAPOLBCES2CES1EPHX2
SCHEMBL7697401 0.93 ALDH1A1 (0.62) NAAAPOLBCES2CES1MEN1
SCHEMBL27989558 0.91 SOAT2 (0.67) NAAAPOLBEPHX2MEN1KMT2A
SCHEMBL8154519 0.91 SOAT2 (0.67) NAAAPOLBEPHX2MEN1KMT2A
SCHEMBL29779165 0.89 SMN1; SMN2 (0.57) POLBCES2CES1EPHX2MEN1
SCHEMBL27581307 0.86 HDAC1 (0.59) HDAC1HDAC8HDAC3HDAC4HDAC2
SCHEMBL3364793 0.86 ALDH1A1 (0.58) NAAACES2CES1MEN1KMT2A
SCHEMBL7270302 0.85 HSD17B3 (0.63) POLBKMT2AALDH1A1HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321130-A1 Senolytic Compositions and Uses Thereof Rubedo Life Sciences, Inc. 2023-10-12 US claimed
US-20210299154-A1 Senolytic Compositions And Uses Thereof Rubedo Life Sciences, Inc. 2021-09-30 US claimed
EP-3790861-A1 SENOLYTIC COMPOSITIONS AND USES THEREOF Rubedo Life Sciences, Inc. (US) 2021-03-17 EP claimed
US-20200016185-A1 SENOLYTIC COMPOSITIONS AND USES THEREOF Rubedo Life Sciences, Inc. 2020-01-16 US claimed
CN-120153233-A Device for visually registering excessive temperatures and method (option) for making same 热力电子有限责任公司 2025-06-13 CN disclosed
US-20230321130-A1 Senolytic Compositions and Uses Thereof Rubedo Life Sciences, Inc. 2023-10-12 US disclosed
US-20210299154-A1 Senolytic Compositions And Uses Thereof Rubedo Life Sciences, Inc. 2021-09-30 US disclosed
US-11026963-B2 Senolytic compositions and uses thereof Rubedo Life Sciences, Inc. (US) 2021-06-08 US disclosed
EP-3790861-A1 SENOLYTIC COMPOSITIONS AND USES THEREOF Rubedo Life Sciences, Inc. (US) 2021-03-17 EP disclosed
US-20200016185-A1 SENOLYTIC COMPOSITIONS AND USES THEREOF Rubedo Life Sciences, Inc. 2020-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210299154-A1 Senolytic Compositions And Uses Thereof SENP3, SENP6, SENP1 NAAA 3752/4885POLB 422/4885CES2 4424/4885
US-11026963-B2 Senolytic compositions and uses thereof SENP3, SENP6, SENP1 NAAA 3752/4885POLB 422/4885CES2 4424/4885
US-20200016185-A1 SENOLYTIC COMPOSITIONS AND USES THEREOF SENP3, SENP6, SENP1 NAAA 3752/4885POLB 422/4885CES2 4424/4885
US-20230321130-A1 Senolytic Compositions and Uses Thereof SENP3, SENP6, SENP1 NAAA 3752/4885POLB 422/4885CES2 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.